News

2022

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Flagship Pioneering appoints Jonathan Schwartz CEO-Partner and CEO of Invaio

Invaio Sciences 12.15.2022

Flagship Pioneering Unveils Montai Health to Treat and Preempt Chronic Disease Afflicting Two Billion People Worldwide

12.13.2022

Flagship Pioneering Names Ron Hovsepian and Robert Berendes 2022 Pioneering Leaders of the Year

Indigo Agriculture 11.18.2022

Flagship Pioneering Announces Appointment of Pablo J. Cagnoni, M.D., as Executive Partner

11.02.2022

Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review

Seres Therapeutics 10.26.2022

David Epstein to Step Down from Consulting Position at Flagship Pioneering

10.17.2022

Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats

Apriori Bio 07.11.2022

Inaugural Indigo Credit Issuance Unlocks Farmer Access to Multi-Billion Dollar Voluntary Carbon Market

Indigo Agriculture 06.29.2022

Harbinger Health and Sarah Cannon Research Institute Launch Clinical Study to Validate and Advance Development of Harbinger’s Novel Early Cancer Detection Platform

06.29.2022

Michael Severino, M.D., Joins Flagship Pioneering-Founded Tessera Therapeutics as Chief Executive Officer

Tessera Therapeutics 06.02.2022

Loading